Kena C. Miller

Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study

Asher Chanan‐Khan, Kena C. Miller, Laurie Musial et al. · Journal of Clinical Oncology · 2006 · 409 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study

Asher Chanan‐Khan, Jonathan L. Kaufman, Jayesh Mehta et al. · Blood · 2006 · 256 citations · Full text

Medicine, Hematology, Pharmacology +14

Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)

Asher Chanan‐Khan, Kena C. Miller, Kenichi Takeshita et al. · Blood · 2005 · 105 citations

Medicine, Oncology, Pharmacotherapy +12

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma

Myron S. Czuczman, Alexandra Fallon, Alice Mohr et al. · Seminars in Oncology · 2002 · 97 citations

Medicine, Oncology, Pharmacotherapy +9

Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response

Asher Chanan‐Khan, Kena C. Miller, David Lawrence et al. · Cancer · 2010 · 88 citations

Life Sciences, Immunology, Oncology +14